๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Physical symptoms in patients with Primary Degenerative Dementia

โœ Scribed by Gary W. Small; Ramanujam Komanduri


Book ID
115841827
Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
350 KB
Volume
27
Category
Article
ISSN
1532-8384

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Lymphopenia in primary degenerative deme
โœ Gary D. Tollefson; Michael Godes J.; Bryan Warren; Erhard Haus; Michael Luxenber ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 700 KB
Psychotic symptoms in patients with deme
โœ Dr. Clive Ballard; Femi Oyebode ๐Ÿ“‚ Article ๐Ÿ“… 1995 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 1002 KB

The current article reviews the current state of knowledge pertaining to psychotic symptoms in patients with dementia, drawing on over 70 studies in this area. The majority of studies utilizing a purpose-designed structured instrument have found a prevalence of psychotic symptoms in excess of 60%. T

Efficacy of oral physostigmine in primar
โœ Suha A. Beller; John E. Overall; Alan C. Swann ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› Springer ๐ŸŒ English โš– 525 KB

To examine the efficacy of cholinergic enhancement in senile dementia of the Alzheimer type (SDAT), oral physostigmine was given to eight patients in a cross-over trial of three dose levels and a matching placebo. A dose-related improvement in memory as measured by objective verbal memory tests was

GROWTH HORMONE SECRETION IN PRIMARY DEGE
โœ ENRICA DI PAOLO; FRANCESCO ZERBI; SABINO PORRO; PIETRO TOSCA; PATRIZIA COSTELLI; ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 590 KB

Changes in brain peptides and neurotransmitters are thought to elicit alterations of growth hormone (GH) secretion in dementia. Baseline GH levels and hormone responses to GH-releasing hormone (GHRH)-administered alone or after pyridostigmine pretreatment-were evaluated in 17 patients, aged 52-83, w